A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advance
A phase 1/2 trial of Gemcitabine, Paclitaxel / nab-paclitaxel, Cetuximab in non-small-cell lung cancer and small-cell lung cancer, run by Bristol-Myers Squibb, now recruiting.
Overview
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies is a phase 1/2 interventional study registered as NCT07223047 by Bristol-Myers Squibb, with 252 participants planned, started 2025-11-25 and due to reach its primary completion in 2028-10-13. Interventions recorded: BMS-986523, Gemcitabine, Nab-Paclitaxel, Cetuximab, Pembrolizumab. Conditions listed: Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Shares Cetuximab, Gemcitabine, Pembrolizumab, Small-cell lung cancer.
- TrialA Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation
Shares Cetuximab, Gemcitabine, Paclitaxel / nab-paclitaxel, Colorectal cancer.
- TrialPhase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Shares Cetuximab, Bristol Myers Squibb, Colorectal cancer.
- TrialA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and P
Shares Bristol Myers Squibb, Pembrolizumab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Pembrolizumab, Small-cell lung cancer.
- TrialPhase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G
Shares Bristol Myers Squibb, Pembrolizumab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Shares Cetuximab, Gemcitabine, Paclitaxel / nab-paclitaxel, Pancreatic ductal adenocarcinoma.
- TrialAn Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
Shares Paclitaxel / nab-paclitaxel, Small-cell lung cancer, Non-small-cell lung cancer.